Blueprint Medicines Corporation
US ˙ NasdaqGS ˙ US09627Y1091
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityBPMC / Blueprint Medicines Corporation
InstitutionPFM Health Sciences, LP
Ownership 2.50%
PFM Health Sciences, LP ownership in BPMC / Blueprint Medicines Corporation

PFM Health Sciences, LP has a history of taking positions in derivatives of the underlying security (BPMC) in the form of stock options.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2017-02-14 2017-02-14 13G/A 2.50 -50.98
2016-03-28 2016-03-28 13G 5.10

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

BPMC / Blueprint Medicines Corporation Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-11-14 2025-09-30 13F BLUEPRINT MEDICINES COM 09627Y109 0 -48,444 -100.00 0 -100.00
2025-08-14 2025-06-30 13F BLUEPRINT MEDICINES COM 09627Y109 48,444 1,991 4.29 6,210 51.03 0.5286
2025-05-15 2025-03-31 13F BLUEPRINT MEDICINES COM 09627Y109 46,453 3,613 8.43 4,112 10.04 0.2985
2025-02-14 2024-12-31 13F BLUEPRINT MEDICINES COM 09627Y109 42,840 42,840 3,737 0.2316
2023-05-15 2023-03-31 13F BLUEPRINT MEDICINES COM 09627Y109 0 -130,366 -100.00 0 -100.00
2023-02-14 2022-12-31 13F BLUEPRINT MEDICINES COM 09627Y109 130,366 0 0.00 5,711 -33.52 0.2045
2022-11-14 2022-09-30 13F BLUEPRINT MEDICINES COM 09627Y109 130,366 130,366 8,590 0.3108
2019-08-14 2019-06-30 13F BLUEPRINT MEDICINES COM 09627Y109 0 -964,075 -100.00 0 -100.00
2019-05-15 2019-03-31 13F BLUEPRINT MEDICINES COM 09627Y109 964,075 -506,361 -34.44 77,174 -2.65 1.7055
2019-02-14 2018-12-31 13F BLUEPRINT MEDICINES COM 09627Y109 1,470,436 30,398 2.11 79,271 -29.48 2.1064
2018-11-13 2018-09-30 13F BLUEPRINT MEDICINES COM 09627Y109 1,440,038 595,957 70.60 112,409 109.79 1.6469
2018-08-14 2018-06-30 13F BLUEPRINT MEDICINES COM 09627Y109 844,081 -73,909 -8.05 53,582 -36.35 0.8390
2018-05-15 2018-03-31 13F BLUEPRINT MEDICINES COM 09627Y109 917,990 51,250 5.91 84,180 28.79 1.7104
2018-02-14 2017-12-31 13F BLUEPRINT MEDICINES COM 09627Y109 866,740 -762,346 -46.80 65,361 -42.41 1.5502
2017-11-14 2017-09-30 13F BLUEPRINT MEDICINES COM 09627Y109 1,629,086 342,636 26.63 113,498 74.12 2.2302
2017-08-14 2017-06-30 13F BLUEPRINT MEDICINES COM 09627Y109 1,286,450 234,438 22.28 65,184 54.94 1.7560
2017-05-15 2017-03-31 13F BLUEPRINT MEDICINES COM 09627Y109 1,052,012 252,061 31.51 42,070 87.49 1.0534
2017-02-14 2016-12-31 13F BLUEPRINT MEDICINES COM 09627Y109 799,951 246,866 44.63 22,439 36.60 0.6324
2016-11-14 2016-09-30 13F BLUEPRINT MEDICINES COM 09627Y109 553,085 -1,093,431 -66.41 16,427 -50.73 0.4809
2016-08-15 2016-06-30 13F BLUEPRINT MEDICINES COM 09627Y109 1,646,516 226,005 15.91 33,342 30.04 1.0060
2016-05-16 2016-03-31 13F BLUEPRINT MEDICINES COM 09627Y109 1,420,511 412,279 40.89 25,640 -3.45 0.7908
2016-02-16 2015-12-31 13F BLUEPRINT MEDICINES COM 09627Y109 1,008,232 -19,321 -1.88 26,557 26.28 0.8069
2015-11-16 2015-09-30 13F BLUEPRINT MEDICINES COM 09627Y109 1,027,553 165,388 19.18 21,030 0.55 0.5916
2015-08-14 2015-06-30 13F BLUEPRINT MEDICINES COM 09627Y109 862,165 862,165 20,916 0.5295
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-05-15 2020-03-31 13F BLUEPRINT MEDICINES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F BLUEPRINT MEDICINES COM Put 336,800 26,981 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.